News

Oscar Health (NYSE:OSCR) used its Investor Day to unveil the Lucy Healthcare Marketplace, an AI-driven platform for carriers, brokers, and consumers. Management outlined a plan to double earnings per share by 2027, describing it as a core pillar of Oscar Health's next phase. CEO statements at the event argued that traditional employer-sponsored health insurance is ending, and Oscar Health aims to focus on individual coverage. The Lucy Healthcare Marketplace launch and Oscar Health's shift...

Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Oscar Health CFO Scott Blackley joins Ashley Mastronardi on NYSE Floor Talk

Oscar Health CFO joins Ashley Mastronardi on NYSE Live to discuss Takeaways from Company’s Investor Day Event

Oscar Health's (OSCR) target of reaching over $4 of earnings per share by 2029 is "predicated on fai

Oscar Health (OSCR) CEO Mark Bertolini sits down with Yahoo Finance Executive Editor Brian Sozzi to discuss the state of the healthcare industry, highlighting why employer-sponsored health insurance might not last forever.

Oscar Health raised its full-year earnings outlook while lowering its expected medical costs to cover benefits for its nearly 3 million Affordable Care Act exchange members. Oscar, which made an aggressive play to gain ACA market share, has seen enrollment surge 47% from a year ago as of June 30, even as overall enrollment has plunged due to the expiration of enhanced premium subsidies. The ACA's No. 2 insurer by membership behind Centene said that it now expects its medical loss ratio, or benefit costs as a share of premiums, to be in the 81% to 82% range, down from the prior outlook of 81.5% to 82.5%.

Oscar Health, Inc. (OSCR) closed at $32.62 in the latest trading session, marking a -3.53% move from the prior day.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

A Federal Reserve rate hike is likely while the crypto Clarity Act faces long odds with a Senate vote on deck. Salesforce holds its Dreamforce conference.

Oscar Health (OSCR) exhibits strong technical momentum, recently setting a new all-time high. The stock is up more than 55% over the past year. OSCR’s fundamentals are robust. Revenue is projected to grow 60.17% this year, with earnings estimated to rise 203.58%. Analyst sentiment is broadly positive, with multiple “Strong...

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its price-to-book multiple tops the industry average.

Oscar Health stock has delivered very strong 3 year gains, yet the broad valuation checks currently lean expensive and do not clearly support it as a bargain. After such a sharp move, investors are trying to work out whether the recent share price now runs ahead of the fundamentals or is still justified by the company’s prospects. Oscar Health has returned about 3.6x over 3 years, which puts extra focus on whether recent gains already reflect much of the potential that investors see in the...

Oscar Health (OSCR) recently reported record first half 2026 results and raised its full year guidance, a combination that appears to have supported renewed investor attention on the stock this month. At a share price of US$30.47, Oscar Health has seen some short term volatility, with a 7 day share price return down 4.9%. However, the 90 day share price return of 37.07% and 3 year total shareholder return of 363.07% suggest momentum has been strong over a longer stretch as investors react to...

Earlier in 2026, Oscar Health reported record first-half financial results and lifted its full-year guidance, prompting analysts to raise their earnings estimates and highlight a low PEG ratio of 0.6 as evidence of relatively modest valuation expectations. This combination of upgraded guidance and analyst estimate revisions underscores how improving profitability expectations are reshaping perceptions of Oscar Health’s earnings power and growth profile. We’ll now examine how Oscar Health’s...

Low P/S and PEG ratios along with a top Zacks Rank. What more could you want?

Urban Outfitters stock tests a buy point while an insurance company bounces off a critical moving average.

Oscar Health (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Dow Jones futures: Crude oil continues to climb while bitcoin jumped again amid a weak dollar. Walmart earnings are in focus.

The S&P 500 and Nasdaq rose slightly Wednesday as Treasury yields fell. Moderna and Merck fueled big gains for biotechs, drugmakers.

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.

Oscar Health stock has delivered a very large 3 year return while the broader valuation checks still lean cautious, with a low value score hinting that the recent re rating may not be a simple bargain story. Oscar Health has returned about 3.6x over the past 3 years, which puts a spotlight on whether recent enthusiasm already prices in much of the progress. Recent profitability and revenue growth can support investor expectations for the business, while concerns around medical cost trends...

Oscar Health’s second quarter saw results well above Wall Street’s expectations, yet the market response was notably negative. Management credited disciplined pricing, technology-driven cost efficiencies, and strong execution in the individual health insurance market for driving year-over-year revenue and margin improvement. CEO Mark Bertolini highlighted that “disciplined pricing, differentiated consumer products and a scalable technology platform” fueled growth, with membership up 46% and admi

Joshua Kushner's Thrive Capital held Amazon shares worth about $215 million as of ‌the end of June, a regulatory filing showed ‌on Friday, adding to the venture capital firm's list of ​tech and AI investments. Known for its early investments in companies that have gone on to dominate their sectors, including OpenAI, SpaceX and Stripe, the venture capital firm has ‌been looking for ⁠opportunities in large technology companies to expand its public-market holdings. • Thrive held 904,038 Amazon ⁠shares valued at $215.5 million as of June 30, the filing showed.

Joshua Kushner’s Thrive Capital has bought up roughly $215 million worth of shares in Amazon.com Inc., building on the venture firm’s push to invest in public companies.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Oscar Health (NYSE:OSCR) and its peers.

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.